Güle Çınar
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
- Hepatology 10
- Hepatitis C virus research 8
-
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- İrem Akdemir Kalkan (18 shared papers)Alpay Azap (9 shared papers)Füsun Can (2 shared papers)Akın Kaya (1 shared paper)Deniz Balcı (2 shared papers)Mehtap Aydın (1 shared paper)Süda Tekin (3 shared papers)Halise Devrımcı Özgüven (1 shared paper)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Viruses (2 papers)Clinical Microbiology and Infection (2 papers)International Journal of Clinical Practice (1 paper)Journal of Medical Microbiology (1 paper)
- Partner nations
- TürkiyeAustraliaUnited States
In The Last Decade
Güle Çınar
36 papers receiving 886 citations
Güle Çınar's Hit Papers
Peers
Comparison fields: 5 of 76
- Infectious Diseases 622
- Health 160
- Modeling and Simulation 49
- Molecular Medicine 49
- Applied Microbiology and Biotechnology 18
Countries citing papers authored by Güle Çınar
This map shows the geographic impact of Güle Çınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Güle Çınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Güle Çınar more than expected).
Fields of papers citing papers by Güle Çınar
This network shows the impact of papers produced by Güle Çınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Güle Çınar. The network helps show where Güle Çınar may publish in the future.
Co-authors
The 25 scholars most cited alongside Güle Çınar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Hit paper breakdown → | 2021 | 701 |
| 2 | 2022 | 35 | |
| 3 | 2020 | 24 | |
| 4 | 2022 | 20 | |
| 5 | 2019 | 11 | |
| 6 | 2023 | 11 | |
| 7 | 2021 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2021 | 6 | |
| 10 | 2020 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2025 | 3 |
About Güle Çınar
Güle Çınar is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 46 papers that have together received 897 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Long-Term Effects of COVID-19 (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Infectious Diseases (622 citations), Health (160 citations), Modeling and Simulation (49 citations), Molecular Medicine (49 citations) and Applied Microbiology and Biotechnology (18 citations). Güle Çınar has collaborated with scholars based in Türkiye, Australia and United States. Frequent co-authors include İrem Akdemir Kalkan, Alpay Azap, Füsun Can, Akın Kaya, Deniz Balcı, Mehtap Aydın, Süda Tekin, Halise Devrımcı Özgüven, Zeynep Ceren Karahan and Şiran Keske. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Viruses, Clinical Microbiology and Infection, International Journal of Clinical Practice and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.